-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Shanghai Hengrui Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-6257 tablets and will conduct clinical trials in the near future.

Zhitongcaijing·12/29/2025 10:01:04
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Shanghai Hengrui Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-6257 tablets and will conduct clinical trials in the near future.